News

Rep. Andy Harris (R-MD) calls on NIH to focus dollars on younger researchers working in areas like Alzheimer's, John Palmer donates $1 million to University of Mississippi MIND Center, and the latest breakthrough in Beta amyloid research (read more).

Sally Quinn talks about Ben Bradlee's struggles with dementia, UK researchers discover an enzyme that could lead to cure for Alzheimer's, and a top executive at Google’s antiaging biotechnology company said this week that scientists must identify and understand the underlying biology of age-related diseases like Alzheimer’s before finding a cure (read more).

Must reads and watch

Pages

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.